JGA Head Frets Majority of Products Subject to Gap-Year Revisions Will Be Generics

JGA President Itsuro Yoshida A plan to cut the NHI reimbursement prices of some drugs in years between regular biennial price revisions will wreak havoc on generic makers and disrupt stable drug supplies, Itsuro Yoshida, president of the Japan Generic...read more